Clinical research is possible because patient volunteers give their consent to participate in trials. Informed consent is a key part of enrolling patients in a clinical trial whereby the potential participant receives all the information they need about their role in the clinical trial.
It is a central part of ICH GCP that informed consent should be freely given
It is a legal requirement for all clinical trials and does not simply involve signing a sheet of paper, it involves patients asking questions and speaking with their physician so that they fully understand what is involved.
While in the past consent was acquired through a traditional pen and paper approach, more recently there has been a growing trend towards electronic consent – eCONSENT. Just like the regular paper-based consent eCONSENT is not merely getting a digital signature. It uses multimedia elements which can be used to develop an interactive and engaging informed consent experience for patient volunteers.
According to the not-for-profit organization TransCelerate, eCONSENT has the potential to improve communications between site staff and patients as well as offering opportunities for greater patient engagement. Proponents of eCONSENT argue that as clinical trials have become increasingly complex so too have consent forms.
Traditional means of gaining consent don’t always cater for varying degrees of literacy and health literacy among patient volunteers. By using alternative media like video, audio and infographics patients may gain better understanding of their participation in clinical trials. Consider for example a clinical trial involving patients with dementia, eCONSENT can offer flexibility in terms of how patient information is presented through multimedia materials tailored to these patients cognitive and communication abilities. eCONSENT also offers a fully traceable digital record of the consent process which will help sponsors with regulatory inspections.
However, some concerns remain about the adoption of this digital approach to consent including issues relating to software standardization, the IT investment required, cybersecurity and data privacy.
While eCONSENT technology has been around for some time the clinical trials sector has been slow to adopt it, preferring to stick with traditional models. However, the COVID-19 pandemic has brought eCONSENT back into the spotlight as CROs and sponsors were forced to rapidly adapt their clinical research models in line with public health restrictions. As the industry pivoted to decentralized trials and remote monitoring eCONSENT has emerged as a major trend that looks set to become firmly established in the years ahead.
Learn more about the regulatory framework around eConsent:
UK’s MRHA on eCONSENT
Cromos Pharma is pleased to share news about our latest project - an international double-blind placebo-controlled clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction (STEMI). The trial involving patients in the US and in Russia will investigate how a biologic RPH-104 developed by R-Pharm can reduce an acute inflammatory response after myocardial infarction and lead to improved outcomes for STEMI patients.
Throughout March we have been highlighting colorectal cancer, the amazing teams of researchers who are continuously fighting this disease, as well as the millions of patients and families who have been deeply affected by this silent killer. To close out this month of awareness-raising we want to introduce you to a real-life hero and colon cancer survivor - Arlene.
March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide according to 2020 figures from the Global Cancer Observatory.
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.